Advertisement
Advertisement
July 9, 2014
Covidien Launches Next-Generation Trellis Peripheral Infusion System
July 8, 2014—Covidien announced the commercial launch of its next-generation Trellis peripheral infusion system, which is currently available in the United States, Europe, and Canada. The redesigned pharmacomechanical thrombolysis device enables focused treatment of blood clots that can lead to post-thrombotic syndrome (PTS). The latest Trellis system has been optimized to enhance drug delivery and the removal of the dissolved clot.
According to Covidien, the Trellis system allows physicians to dissolve acute thrombus and intervene on DVT before it advances to PTS. The system is composed of an over-the-wire catheter with two occlusive balloons to close off the treatment area and block drug release to other areas of the body, an infusion zone to deliver the lytic drug, and an oscillation drive unit that disperses the drug to dissolve the clot.
In addition to its enhanced drug delivery, the updated Trellis system features increased amplitude of the dispersion wire to better distribute the drug throughout the clot and a larger aspiration window than the previous version to allow for better removal of the drug and the dissolved clot, stated the company.
Advertisement
Advertisement
